Olezarsen sodium, an N-acetyl-galactosamine-conjugated antisense oligonucleotide, targets hepatic APOC3 mRNA to suppress the production of apolipoprotein C-III (apoC-III). This action helps reduce triglyceride levels in patients at high risk for or with established cardiovascular disease.
CAS Number:
[2298451-31-5]
* VAT and and shipping costs not included. Errors and price changes excepted
